about
Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancerAmifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancerClinical Studies of Nonpharmacological Methods to Minimize Salivary Gland Damage after Radioiodine Therapy of Differentiated Thyroid Carcinoma: Systematic ReviewSialoendoscopy: state of the art, challenges and further perspectives. Round Table, 101(st) SIO National Congress, Catania 2014Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk PatientsSialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone--thyrotropin alfa).2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerMonte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PETInterventional sialendoscopy for radioiodine-induced sialadenitis: quo vadis?Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.Significance of Salivary Gland Radioiodine Retention on Post-ablation (131)I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated Thyroid CarcinomaNeonatal hyperthyroidism associated with isolated submandibular sialadenitis: is it just a coincidence?Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction.Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.Salivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy.Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid CancerAdverse drug reactions in the orofacial region.Micro-single-photon emission computed tomography image acquisition and quantification of sodium-iodide symporter-mediated radionuclide accumulation in mouse thyroid and salivary glands.Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake.S values for 131I based on the ICRP adult voxel phantoms.A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy.Hybrid Intercalated Duct Lesion of the Parotid: Diagnostic Challenges of a Recently Described Entity with Fine Needle Aspiration Findings.Modulation of sodium/iodide symporter expression in the salivary glandRadioprotective Effect of Epigallocatechin-3-Gallate on Salivary Gland Dysfunction After Radioiodine Ablation in a Murine ModelNew developments in the diagnosis and treatment of thyroid cancer.On approaches to the functional restoration of salivary glands damaged by radiation therapy for head and neck cancer, with a review of related aspects of salivary gland morphology and development.Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia.Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer.Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management.Long-term outcomes of distant metastasis from differentiated thyroid carcinoma.Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy.Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros.Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models.Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.Impact of thyroidectomy on cardiac manifestations of Graves' disease.Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients.Usefulness of Magnetic Resonance Sialography for the Evaluation of Radioactive Iodine-Induced Sialadenitis.(131)I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study.Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
P2860
Q24240279-69393532-D726-48A5-B5EE-7387AADFB6D9Q24240711-6F74825E-127E-42FE-BC0D-F95E8C3DC834Q26742132-99DBAA87-804A-4FB2-BC7A-6442910E0870Q26772994-26BCA1ED-DEE4-4C0B-B7AF-B79A0D0618A5Q26797677-DE9120F2-80D7-495A-8AC1-018E7E002B8DQ30277985-D77F1928-40A5-4987-B9DD-D43C25825AE0Q30367068-A7B1E1F8-705A-4489-A841-0B7536087872Q33682852-6C23F6BC-ABBD-400A-8771-6D567CF2D530Q33777034-BE4C5CA4-90D7-4F3D-8BF7-327F1ECD0120Q33833660-79B01C7D-ED92-44DD-B751-4F976D369E04Q34090852-AE14FB5E-275A-4DE8-8D1D-5A995F67BD64Q34423115-D32FC3AB-48E0-439E-A761-EA427048F227Q34712784-BEC2F287-3CBE-4CE7-811A-80971B966329Q35057314-86F62EA0-C6D4-4C67-B83D-01D5C1FCE416Q35163702-E4B689C1-A443-4B04-80A5-3084B517EB08Q35750722-7860385E-F573-46D0-AECB-3F18F9FEE77CQ35778563-382C5AEA-14EC-45D1-A874-868269BDD4CBQ35850842-6939BFD0-3409-43B6-A57C-6CFD5944E2B7Q35979708-9DCB3571-1AF4-4176-A6E2-C54C15099C26Q35979713-D69CFE2B-1FB4-4F1B-A611-9BB73D9035C5Q36509422-1DCEF6B4-E2E6-48C3-AE6C-936FBC267D16Q36811424-B08F9576-2CE1-4D8D-9663-C8B76DA0B92BQ36819945-31BA5F0D-4FDD-44CA-94ED-F923AEE1D025Q37118674-8620D881-249B-4501-A93F-64AB14686E72Q37200420-EFC63280-E462-4D1A-A930-F2D9940C8750Q37238757-9E6110B6-C2CA-42F1-976E-0A0AAB3DAA04Q37283589-FFBCA5AD-151A-46F4-B70F-00060ED93EA8Q37428548-17FD7233-0ACC-48AE-90FB-620420BE44CEQ37804443-12EF0390-5214-4A64-8419-5297A291762CQ37815386-3A8EE206-BB1F-4C9A-9CEB-9C5E23C0659DQ37939266-77D89020-3E45-4E15-9C4E-E0BE3A4B2C31Q38125502-87A5CD86-800C-4A26-94E8-38BF2F4F861FQ38537454-35C70908-1C52-4919-AA1D-ABDA7110ED1CQ38633284-F9BA4B39-6807-4896-8B46-8C23F6A57440Q39204422-0523E322-643A-4981-8FB0-DA5B798A3B9FQ39959067-E404B26B-116C-4824-AA77-6B0D0D7FF091Q40492966-7AB55D19-DFFB-4DEF-AABB-3CDEDE856D99Q40661029-D596A910-FF9B-4906-A507-06B7D2A96C7CQ41031855-BC7EFD75-AB05-4E36-BCDE-CAFD6E3E0B93Q41148634-96C88DC3-54D1-423E-85F9-4025CBAF85CF
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Radioactive iodine and the salivary glands.
@ast
Radioactive iodine and the salivary glands.
@en
type
label
Radioactive iodine and the salivary glands.
@ast
Radioactive iodine and the salivary glands.
@en
prefLabel
Radioactive iodine and the salivary glands.
@ast
Radioactive iodine and the salivary glands.
@en
P1433
P1476
Radioactive iodine and the salivary glands.
@en
P2093
Louis Mandel
Susan J Mandel
P304
P356
10.1089/105072503321582060
P577
2003-03-01T00:00:00Z